Trial Profile
Dexlansoprazole MR in Nonerosive Reflux Disease
Status:
Active, no longer recruiting
Phase of Trial:
Phase III
Latest Information Update: 06 Jul 2017
Price :
$35
*
At a glance
- Drugs Dexlansoprazole (Primary)
- Indications Gastro-oesophageal reflux
- Focus Therapeutic Use
- 07 Jul 2015 New trial record